SC: Pre-2015 NH Act Awards Must Follow 1894 Act for Solatium and Interest  ||  SC: Service Rendered Before Regularization Must Be Counted for Pension Benefits  ||  SC: Rajpal Yadav gets Relief from Surrender in Cheque Bounce Case Subject to Rs. 5 Crore Deposit  ||  Gauhati High Court: Local NGOs Cannot Lock Homes Over Alleged Liquor Law Violations  ||  Madras High Court: Environmental, PCB Clearances Not Needed for Medical Essentiality Certificate  ||  Tripura HC: Police Report Not Contemplated By Rules Alone Cannot Be Basis to Deny Premature Release  ||  P&H HC: Senior Citizens Act cannot Remove Estranged Daughter-In-Law from Shared Home  ||  P&H HC: Foreign Licence Alone Does Not Authorize Driving in India  ||  Allahabad HC: Parental Concern Cannot Override Adult’s Choice of Life Partner  ||  Calcutta HC: Defamation Injunction Requires Truth Defence to Be Clearly Unsustainable    

Glenmark Settles Patent Litigation over Milnacipran Hydrochloride Tablets - (22 Dec 2015)

Glenmark Pharmaceuticals Inc., USA have entered into a settlement agreement with Forest Laboratories, LLC, Forest Laboratories Holdings, and Royalty Pharma Collection Trust to settle and dismissed outstanding patent litigation related to Glenmark's Abbreviated New Drug Application.

Tags : GLENMARK PHARMACEUTICALS INC   FOREST LABORATORIES   LLC   FOREST LABORATORIES HOLDINGS     ROYALTY PHARMA COLLECTION TRUST  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved